Lv31
350 积分 2024-10-28 加入
T-Cell Engagers in Lung Cancer: A Comprehensive Literature Review from Tarlatamab Approval to Next-Generation Strategies
9天前
已完结
Clinical Responses to Tarlatamab Among Patients with Pulmonary Carcinoid
9天前
已完结
Comparative efficacy of tarlatamab and second-line therapies in extensive-stage small cell lung cancer: A network meta-analysis
10天前
已完结
The changing therapeutic landscape of small-cell lung cancer
17天前
已完结
Patterns of Response to Durvalumab Plus Tremelimumab and Atezolizumab Plus Bevacizumab in Patients With Unresectable Hepatocellular Carcinoma
22天前
已完结
Combination lurbinectedin and doxorubicin versus physician's choice of chemotherapy in patients with relapsed small-cell lung cancer (ATLANTIS): a multicentre, randomised, open-label, phase 3 trial
29天前
已完结
Small Cell Lung Cancer
29天前
已关闭
Small Cell Lung Cancer
29天前
已完结
Vorasidenib in IDH1-mutant or IDH2-mutant low-grade glioma (INDIGO): secondary and exploratory endpoints from a randomised, double-blind, placebo-controlled, phase 3 trial
1个月前
已完结
Overcoming therapy resistance in EGFR-mutant lung cancer
1个月前
已完结
Horns and Beaks: Ceratopsian and Ornithopod Dinosaurs
皖公网安备34019202002308
